NorthWest Biotherapeutics Inc (NWBO)

[Gus McCrae]

That's probably why their strategy is to support the post TLD price with a series of news to keep it above $4 for 90 days to uplist, IMO. If they reported TLD and wait 9 or 10 months for journal, that will negatively affect the price and take the wind out of any bounce on that news and from a lower level.

I don't think this is possible with just news alone on the OTC, certainly not for 90 days. I think the only way we can sustain $4.00 is if the PIPE transaction is done at, say $6.00 per share...and one of the purchasers is a big pharma company or other heavy hitter.

If that doesn't happen, then we are going to have to do a R/S in the spring for uplisting purposes...of course, if they knew they were going to be in this position in the spring, which they would have to have known, then they should have gone ahead and gotten the R/S over with then so that they could uplist closer to when TLD is released. So, maybe they have another plan to facilitate uplisting, like a "white knight" PIPE purchaser.

For those of you who have been speculating about a quick buyout after the release of TLD, this is how it happens: (i) TLD AND the PIPE transaction are announced at the same time... 20.0 million shares are sold to big pharma for $6.00 per share; (ii) market sees the writing on the wall and goes crazy, up to $10.00 per share; (iii) big pharma announces acquisition of NWBO for $15.00 per share, a reasonable premium for big pharma to pay. Highly, highly unlikely, but a man can dream.